Category Archives: BioInformatics

Indiana Universitys first Grand Challenge initiative, Precision Health, has recruited Kun Huang to serve as director of data sciences and informatics for the $300 million, five-year research project, which was first announced in June 2016. Huang is a professor of biomedical informatics at the Ohio State University, where he also serves as associate dean for genome informatics in the College of Medicine and director of the Division of Computational Biology and Bioinformatics. He will join IU on July 17. [Also:The dawn of precision medicine has begun, ONC says] Huang is recognized internationally for his work in bioinformatics and computing He has focused his research on translational bioinformatics and integrative genomics tools for precision health, algorithms and software employed to visualize large and complex biomedical data, computer vision, machine learning, medical imaging and computational biology. In addition to his role as director of data sciences and informatics for the Precision Health Initiative. At IU, Huang will lead the development of innovative informatics solutions as part of the universitys Precision Health Initiative, which is focused on patient-centered precision medicine therapies. He also will serve as chair in genomic data sciences for the Precision Health Initiative and as assistant dean for data sciences, … Continue reading →

news Understanding evolution is one of the cornerstones of biology evolution is, in fact, the sole explanation for lifes diversity on our planet. Based on the evolution of proteins, researchers may explain the emergence of new species and functions through genetic changes or how enzymes with novel functions might be engineered. One popular approach to the study of evolution is to compare genome data using bioinformatics tools. Scientists using these approaches may compare specific proteins, which consist of combinations of 20 universal building blocks, called amino acids. So far, the bioinformatics tools used to study the evolution of single proteins have assumed that the speed at which different regions of proteins evolve can be modelled with a statistical distribution whose shape is determined by a single variable. That assumption, however, does not reflect reality, and it might have led to a large proportion of biased phylogenetic results being published over the last two decades or so, explains Minh Quang Bui, from the Center for Integrative Bioinformatics (CIBIV). Arndt von Haeseler, group leader at the Max F Perutz Laboratories (MFPL) and Lars Jermiin from the Australian National University have now found a revolutionary way of implementing different rates of evolution into … Continue reading →

(MENAFN Editorial) According to report published by Grand View research, global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years. The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years. Further development of bioinformatics tools, platforms and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry. European bioinformatics market, by product, 2012 - 2020 (USD Million) Bio-content processing accounted for over 47% of the revenue share in 2013. The presence of increasing market demand for genetic databases … Continue reading →

Clustered regularly interspaced short palindromic repeats (Crispr) and its associated protein (Cas9) have been generating quite a buzz of late, even resulting in speculation about a new technology race between the US and China. Political and strategic implications apart, scientists all over the world are now able to carry out gene editing at costs much lower than ever before, and much more accurately. The enhanced tinkering with deoxyribonucleic acid (DNA)the building blocks of lifecan be used to achieve end goals as diverse as enhancing crop quality and disease resistance, treating genetic diseases, and even addressing the associated risk of antibiotic resistance through a Crispr pill that substitutes antibiotics. But the media attention hogged by this technology should not blind us to new advances in ribonucleic acid (RNA) research. This polymeric moleculeessential for regulation and expression of geneshas already been the subject of research, in areas such as RNA interference (RNAi) and antisense technology. While RNAi is a gene silencing technology that inhibits protein synthesis in target cells using double-stranded RNA, antisense technology achieves the same result through single-stranded RNA. RNAi has huge significance within the Indian context, considering the deep-seated resistance over the years to Bt cotton and other genetically … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)--H3 Biomedicine Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisais global Oncology Business Group, announced today that Lihua Yu, Ph.D., has been promoted to Chief Data Sciences Officer (CDSO). Dr. Yu previously served as H3 Biomedicines Vice President, Data Science and Information Technology. Lihuas appointment to Chief Data Sciences Officer fills a critical element in H3s step towards building a comprehensive oncology pipeline and supporting the next generation of novel cancer drugs, said Markus Warmuth, M.D., President and CEO of H3 Biomedicine. Lihuas proven commitment and expertise in establishing and expanding the use of data technology at H3 helped fuel the companys growth through the integration of data science and cancer genomics, which has rapidly generated a superior informatics analysis engine. In her new role, Dr. Yu will oversee H3 Biomedicines computational biology and data mining activities, including the management of the companys cancer genomics and pharmacogenomics data. Additionally, she will supervise the identification and integration of all data analysis capabilities for discovery, preclinical and clinical data. Dr. Yu will also lead the Discovery Informatics team in developing genomics data management, integration, and exploration … Continue reading →

From cancer to vector-borne diseases, and from drug development to monitoring invasive species, DNA sequencing is vital to the research being done at the University of Notre Dame. To support these research efforts, the Genomics and Bioinformatics Core Facility (GBCF) has acquired an illumina NextSeq 500 Sequencing System, for next generation high-throughput genomics sequencing. The new machine supports a broad range of applications that can sequence millions of DNA fragments. To explain the benefits of the new equipment, Michael Pfrender, associate professor of biological sciences and director of the GBCF, said, By providing the research community access to industry-leading technology, the GBCF will be able to better support researchers who increasingly rely on high-throughput DNA sequencing to complete their work. This equipment increases sequencing availability and flexibility, further expanding research and collaborative potential. The illumina NextSeq 500 Sequencing System will complement existing GBCF equipment with key applications including whole genome, exome, or transcriptome sequencing, thereby providing exceptional data accuracy at any coverage level. Additionally, the facility now has the capability to perform high throughput next generation sequencing in house at a low-cost per base with faster results. This will allow faculty to utilize the GBCF staffs expertise in data generation … Continue reading →

| James Kon | THE Republic of Korea remained the second largest trading partner of Brunei Darussalam in 2016 with total trade worth B$1.094 billion. The majority of the export to Korea from Brunei Darussalam is oil and gas. Actually, the trade volume is still the same but the value shows a slight reduction compared to 2015 because of the fall in oil and gas prices, the South Korean Ambassador to Brunei Darussalam Cho Won-myung said. In an interview at the Korean Embassy in the diplomatic enclave recently, the envoy told the Weekend Bulletin that Korea and Brunei are very important partners of trade and our government would like to thank Brunei Darussalam for providing a stable energy source to Korea. With the new chancery in place, he stressed that the Korean Embassy in Brunei Darussalam is continuing its efforts to expand the volume of trade between both countries in the long term, hoping that Brunei companies would import high-quality Korean products such as building materials and food products. Cho Won-myung cited that the potential of foreign investments from Korea in Brunei would be in medical and high-tech industry. Two years ago, I had invited a Korean bioinformatics company which … Continue reading →

The purpose of Global Bioinformatics Market report is to provide the newest industry data and Bioinformatics industry future trends, allowing consumers to identify the Bioinformatics market Application, Type, Manufacturers, and Regions, Bioinformatics market Forecast up to 2022. 2017 Global Bioinformatics Market lists the ruling vendors and provides the significant industry analysis of the key terms influencing the Bioinformatics market. Along with a consequential data of 2016, global Bioinformatics market report also provides forecast from 2017 to 2022 based on Bioinformatics industry volume and Bioinformatics revenue (USD Million). The Bioinformatics Market report encompasses forecasts, analysis and discussion of trade facts, Bioinformatics market size, evaluation of market share and profiles of the famous Bioinformatics industry players on a global and regional level. Do Inquiry Before Accessing Report Here: https://market.biz/report/global-bioinformatics-market-gir/27170/#inquiry IBM Life Sciences BIOVIA Life Technologies Corporation Agilent technologies 3rd Millennium Celera Corporation Affymetrix, BioWisdom Rosetta Biosoftware Bio-content processing Metabolomics Molecular Phylogenetics Hospitals & Clinics Healthcare institutions Research & Clinical laboratories Europe Bioinformatics Market(Germany, France, Italy, Russia and UK) North America Bioinformatics Market (Canada, USA and Mexico) Latin America Bioinformatics Market (Middle and Africa). Bioinformatics Market in Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Asia-Pacific Bioinformatics Market (South-east … Continue reading →

Laureates 2016 - Benjamin Langmead Benjamin Langmead is one of the most influential and highly cited authors of open source bioinformatics software. His Bowtie read alignment tool and its sequel Bowtie 2 (bowtie-bio.sourceforge.net/bowtie2/index.shtml) are widely used, with more than 10,000 citations between them, and they are used within more than 50 other software tools. Ben also has a series of publications on open source cloud-enabled tools that have collectively pushed back the frontier of what everyday biological researchers can do with large sequencing datasets. All of Ben's software, and all the software from his lab, are free and open source. He has also made available a large collection of open teaching resources that have become very popular (www.langmead-lab.org/teaching-materials/). 2015 - Owen White Owen White has been a leading proponent of open access software since the late 1990's, when he worked as the Director of Bioinformatics at The Institute for Genomic Research (TIGR). At TIGR and in the years since then, he has consistently advocated for the free release of software and of genome sequence data. He led the development of the Comprehensive Microbial Resource (first published in 2001), one of the first and at the time one of the largest … Continue reading →

Kansas City Business Journal Conference stresses how big data can improve human and animal health Kansas City Business Journal The conference on bioinformatics or the collection, analysis and use of biological data is one of a series of efforts to bring together some of the brightest minds from the region's 260-mile animal health corridor, stretching from Manhattan to ... Here is the original post: Conference stresses how big data can improve human and animal health - Kansas City Business Journal … Continue reading →